Reactions 1680, p207 - 2 Dec 2017 Neurotoxicity: 2 case reports A 54-year-old man and a 76-year-old man developed lithium neurotoxicity [routes and time to reactions onsets not stated]. A 76-year-old man, who had bipolar I disorder, started receiving therapy with lithium 300mg twice daily. He was hospitalised with a diagnosis of mixed manic-depressive disorder. At the time of admission, he was confused and experienced balancing difficulty. A total work up of delirium showed no clear cause. Following a neurological consultation, diagnosis of delirium was agreed upon, and lithium neurotoxicity was suggested despite of normal lithium therapeutic level of 0.71 (lithium therapeutic range: 0.6-1.2). Later on, his delirium improved and eventually resolved after lithium withdrawal. A 54-year-old man, who had schizophrenia, started receiving therapy with lithium 300mg twice daily and clozapine. Later, he presented with recurrent falls related to postural instability. His lithium level was 0.6 (lithium therapeutic range: 0.6-1.2). Diagnosis of lithium neurotoxicity was made with lithium being within therapeutic levels. His motor difficulties recovered after discontinuation of lithium treatment. Author comment: "Because lithium neurotoxicity may occur with therapeutic serum levels, and may occasionally be irreversible, lithium should be discontinued until it is clear that it is not contributing to the neurological dysfunction." "We present two cases of lithium neurotoxicity within therapeutic lithium levels." Moustafa Y, et al. Lithium-induced neurotoxicity at therapeutic levels: Illustrative cases and literature review. CNS Spectrums 22: 104-105, No. 1, Feb 2017. Available from: URL: http://doi.org/10.1017/S1092852916000900 [abstract] - USA 803284752 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera